Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E

Low density lipoprotein receptor deficient (LDLR-KO) and apolipoprotein E deficient (apo E-KO) mice both develop hyperlipidemia and atherosclerosis by different mechanisms. The aim of the present study was to compare the effects of simvastatin on cholesterol levels, endothelial dysfunction, and aort...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2002-05, Vol.162 (1), p.23-31
Hauptverfasser: Wang, Yi-Xin (Jim), Martin-McNulty, Baby, Huw, Ling-Yuh, da Cunha, Valdeci, Post, Joe, Hinchman, Josephine, Vergona, Ronald, Sullivan, Mark E., Dole, William, Kauser, Katalin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Low density lipoprotein receptor deficient (LDLR-KO) and apolipoprotein E deficient (apo E-KO) mice both develop hyperlipidemia and atherosclerosis by different mechanisms. The aim of the present study was to compare the effects of simvastatin on cholesterol levels, endothelial dysfunction, and aortic lesions in these two models of experimental atherosclerosis. Male LDLR-KO mice fed a high cholesterol (HC; 1%) diet developed atherosclerosis at 8 months of age with hypercholesterolemia. The addition of simvastatin (300 mg/kg daily) to the HC diet for 2 more months lowered total cholesterol levels by ∼57% and reduced aortic plaque area by ∼15% compared with the LDLR-KO mice continued on HC diet alone, P
ISSN:0021-9150
1879-1484
DOI:10.1016/S0021-9150(01)00678-5